NCT00461500View on ClinicalTrials.gov

SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults

PHASE4CompletedINTERVENTIONAL

Enrollment

81

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Asthma

Interventions

DRUG

Salmeterol xinafoate/fluticasone propionate combination

SFC 100

DRUG

Fluticasone propionate

FP 100

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY